Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells

Journal of Pineal Research

Volumn 53, Issue 1, 2012, Pages 91-98

  Uguz, Abdulhadi C ^a   Cig, Bilal ^a   Espino, Javier ^b   Bejarano, Ignacio ^b   Naziroglu, Mustafa ^a   Rodríguez, Ana B ^b   Pariente, José A ^b  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Apoptosis; AR42J cells; Chemotherapy; Cytotoxicity; Melatonin

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MELATONIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PANCREAS CANCER; RAT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MELATONIN; PANCREATIC NEOPLASMS; RATS; TIME FACTORS;

EID: 84863595623     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2012.00974.x     Document Type: Article

References (46)

1. Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res 2010; 181:127-151.
2. Cardinali DP, Esquifino AI, Srinivasan V et al. Melatonin and the immune system in aging. Neuroimmunomodulat 2008; 15:272-278.
3. Carrillo-Vico A, Guerrero JM, Lardone PJ et al. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27:189-200.
4. Reiter RJ, Tan DX, Manchester LC et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007; 52:11-28.
5. GonzalezA, DelCastillo-VaqueroA, Miro-MoranAet al. Melatonin reduces pancreatic tumor cells viability by altering mitochondrial physiology. J Pineal Res 2011; 50:250-260.
6. Trubiani O, Recchioni R, Moroni F et al. Melatonin provokes cell death in human B-lymphoma cells by mitochondrialdependent apoptotic pathway activation. J Pineal Res 2005; 39:425-431.
7. Rubio S, Estévez F, Cabrera J et al. Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells. J Pineal Res 2007; 42:131-138.
8. Garcia-Santos G, Antolin I, Herrera F et al. Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 2006; 41:130-135.
9. Blask DE, Hill SM, Dauchy RT et al. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res 2011; 51:259-269.
10. Blask DE, Dauchy RT, Sauer LA et al. Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Res Treat 2003; 79:313-320.
11. Hill SM, Cheng C, Yuan L et al. Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin. Breast Cancer Res Treat 2001; 127:91-98.
12. González A, Alvarez-Garća V, Mart́nez-Campa C et al. In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin. Curr Cancer Drug Targets 2010; 10:279-286.
13. Tan DX, Chen LD, Poeggeler B et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
14. Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51:1-16.
15. Lissoni P, Barni S, Mandala M et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer 1999; 35:1688-1692.
16. Reiter RJ, Tan DX, Sainz RM et al. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002; 54:1299-1321.
17. Hu W, Kavanagh JJ. Anticancer therapy targeting the apoptotic pathway. Lancet 2003; 4:721-729.
18. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004; 116:205-219.
19. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281:1309-1312.
20. Kim CH, Kim KH, Yoo YM. Melatonin protects against apoptotic and autophagic cell death in C2C12 murine myoblast cells. J Pineal Res 2011; 50:241-249.
21. Jou MJ, Peng TI, Yu PZ et al. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res 2007; 43:389-403.
22. Espino J, Bejarano I, Paredes SD et al. Protective effect of melatonin against human leukocyte apoptosis induced by intracellular calcium overload: relation with its antioxidant actions. J Pineal Res 2011; 51:195-206.
23. Sainz RM, Mayo JC, Rodriguez C et al. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003; 60:1407-1426.
24. Bejarano I, Redondo PC, Espino J et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009; 46:392-400.
25. Garcia-Navarro A, Gonzalez-Puga C, Escames G et al. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. J Pineal Res 2007; 43:195-205.
26. Wenzel U, Nickel A, Daniel H. Melatonin potentiates flavone-induced apoptosis in human colon cancer cells by increasing the level of glycolytic end products. Int J Cancer 2005; 116:236-242.
27. Leja-Szpak A, Jaworek J, Pierzchalski P, Reiter RJ. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res 2010; 49:248-255.
28. Büyü kavci M, Ozdemir O, Buck S et al. Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukaemia cells. In Vivo 2011; 25:405-409.
29. Koh W, Jeond S-J, Lee H-J et al. Melatonin promotes puromycin-induced apoptosis with activation of caspase-3 and 5-adenosine monophosphate-activated kinase-alpha in human leukaemia HL-60 cells. J Pineal Res 2011; 50:367-373.
30. Fan L-L, Sun G-P, Wang Z-G et al. Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines. World J Gastroenterol 2010; 16:1473-1481.
31. Casado-Zapico S, Rodriguez-Blanco J, Garcia-Santos G et al. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway. J Pineal Res 2010; 48:72-80.
32. Kim J-H, Jeong S-J, Kim B et al. Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells. J Pineal Res 2012; 52:244-252.
33. Majsterek I, Gloc E, Blasiak J et al. A comparison of the action of amifostine and melatonin on DNA-damaging effects and apoptosis induced by idarubicin in normal and cancer cells. J Pineal Res 2005; 38:254-263.
34. Cjinery R, Brockman JA, Peerler MO et al. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer. Nat Med 1997; 3:1233-1237.
35. Lissoni P. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms. Pathol Biol 2007; 55:201-204.
36. Bejarano I, Espino J, Marchena AM et al. Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells. Mol Cell Biochem 2011; 353:167-176.
37. Bejarano I, Espino J, Barriga C et al. Pro-oxidant effect of melatonin in tumour leucocytes: relation with its cytotoxic and pro-apoptotic effects. Basic Clin Pharmacol Toxicol 2011; 108:14-20.
38. Radogna F, Paternoster L, De Nicola M et al. Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes. Toxicol Appl Pharmacol 2009; 239:37-45.
39. Christophe J. Pancreatic tumoral cell line AR42J: an amphicrine model. Am J Physiol 1994; 266:G963-G971.
40. Joo SS, Yoo YM. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res 2009; 47:8-14.
41. Hermann R, Podhajsky S, Jungnickel S et al. Potentiation of antiproliferative effects of tamoxifen and ethanol on mouse hepatoma cells by melatonin: possible involvement of mitogenactivated protein kinase and induction of apoptosis. J Pineal Res 2002; 33:8-13.
42. Fic M, Podhorska-Okolow M, Dziegiel P. et al. Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2). In Vivo 2007; 21:513-518.
43. Hassan MI, Ahmed MI, Kassim SK et al. Cis-platinuminduced immunosuppression: relationship to melatonin in human peripheral blood mononuclear cells. Clin Biochem 1999; 32:621-626.
44. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78:539-542.
45. Panaretakis T, Pokrovskaja K, Shoshan MC et al. Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. J Biol Chem 2002; 277:44317-44326.
46. Tripathi DN, Jena GB. Effect of melatonin on the expression of Nrf2 and NF-jB during cyclophosphamide-induced urinary bladder injury in rat. J Pineal Res 2010; 48:324-331.